表紙
市場調查報告書
商品編碼
1069934

分子診斷劑:技術和全球市場

Molecular Diagnostics: Technologies and Global Markets

出版日期: | 出版商: BCC Research | 英文 204 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

2021年全球分子診斷市場規模達到176億美元。

預計從 2021 年到 2026 年,該市場將以 19.3% 的複合年增長率增長,到 2026 年將達到 426 億美元。

本報告調查了全球分子診斷市場,並提供了市場概況,以及技術、應用、地區和進入市場的公司概況的趨勢。

目錄

第一章介紹

第二章總結與重點

第三章概述

  • 基因組診斷簡介
  • 表達譜和疾病
  • 表達譜和傳染病
  • 用於基因分型和診斷的 DNA 測序
  • 臨床藥理學
  • 特定基因的突變檢測和基因分型
  • 新疾病的基因鑑定

第 4 章 COVID-19 大流行的影響

  • 簡介
  • COVID-19 對市場的影響
  • 健康相關產品消費趨勢變化

第五章市場動態

  • 市場促進因素
  • 抑制因素和挑戰
  • 市場機會

第 6 章市場細分,按技術

  • 微陣列
  • 概覽
  • 微流控裝置
  • 聚合□鏈反應
  • 原位雜交
  • 標籤技術
  • 纖維魚
  • Her2 魚測試
  • 其他

第 7 章分子診斷藥物市場,按應用

  • 傳染病
  • 腫瘤學
  • 白血病
  • 慢性粒細胞白血病
  • 慢性粒細胞白血病的遺傳標誌物
  • 產前產後篩查
  • 職業篩選
  • 產前診斷測試
  • 羊膜穿刺術
  • 絨毛取樣
  • 遺傳諮詢
  • 胚胎植入前基因診斷
  • 新生兒篩查
  • 市場規模和預測
  • 身份證/親子關係確認檢查
  • 親子鑑定
  • 技術
  • 認證
  • 法律問題
  • 獸醫鑑定測試
  • 其他

第 8 章市場細分,按地區

  • 按地區分列的全球分子診斷藥物市場
  • 北美
  • 歐洲
  • 亞太地區
  • 其他領域

第9章監管和財政

  • 概覽
  • 歐洲
  • 美國
  • 日本
  • 保險
  • 食品藥品監督管理局指南
  • DNA診斷內標
  • 關於微陣列的最少信息
  • 實驗:MIAME 2.0
  • 芯片質量控制項目
  • 實驗室改進的修正
  • 個性化醫療和伴隨診斷
  • FDA 體外伴隨診斷指南
  • 體外診斷伴隨診斷設備的定義和使用
  • 體外診斷配套診斷裝置及治療藥物審評審批
  • 新型治療劑
  • 一般政策
  • 已獲批准的 IVD 配套診斷設備批准,無需診斷設備
  • FDA 批准的伴隨診斷
  • 核酸檢測
  • 藥理基因組學研究網

第10章專利

第11章競爭態勢

  • 概覽

第 12 章公司簡介

  • ABBOTT
  • AGILENT TECHNOLOGIES INC.
  • ALMAC GROUP
  • BECTON, DICKINSON AND CO.
  • BIOMERIEUX SA
  • BIO-RAD LABORATORIES INC.
  • CARDINAL HEALTH
  • DANAHER CORP.
  • ELITECH GROUP
  • GENERAL ELECTRIC
  • HOLOGIC INC.
  • ILLUMINA INC.
  • MYRIAD GENETICS
  • GRIFOLS(NOVARTIS MOLECULAR DIAGNOSTICS)
  • PHILIPS HEALTHCARE
  • QIAGEN N.V.
  • QUEST DIAGNOSTICS
  • ROCHE HOLDING AG(F. HOFFMANN-LA ROCHE LTD.)
  • SIEMENS HEALTHCARE
  • THERMO FISHER SCIENTIFIC INC.
目錄
Product Code: BIO063E

Highlights:

The global molecular diagnostics market should reach $42.6 billion by 2026 from $17.6 billion in 2021 at a compound annual growth rate (CAGR) of 19.3% for the forecast period of 2021 to 2026.

The North American molecular diagnostics market is expected to grow from $7.6 billion in 2021 to $17.1 billion in 2026 at a CAGR of 17.5% for the forecast period of 2021 to 2026.

The European molecular diagnostics market is expected to grow from $4.7 billion in 2021 to $11.9 billion in 2026 at a CAGR of 20.1% for the forecast period of 2021 to 2026.

Report Scope:

This study examines the global market for assays used to detect specific nucleic acid sequences in medical and life science applications. The goal of all DNA-based diagnostic assays is similar, but several different technologies can be employed. BCC Research analyzes each technology in detail, determines major players and current market status, and presents forecasts of growth over the next five years. Scientific challenges and advances, including the latest trends, are emphasized. Government regulations, major collaborations, recent patents and factors affecting the industry from a global perspective are examined. New directions for DNA diagnostic technologies and emerging applications in clinical diagnostics are also examined.

Key molecular diagnostic technologies and products are analyzed to determine present and future market status, and growth is forecast from 2021 to 2026. In-depth discussion of strategic alliances, industry structures, competitive dynamics, patents and market driving forces are also provided.

Report Includes:

  • 60 tables
  • An overview of the global market and technologies for molecular diagnostics
  • Estimation of the market size and analyses of global market trends, with data from 2019 to 2021 and projections of compound annual growth rates (CAGRs) through 2026
  • Characterization and quantification of market potential for molecular diagnostic technologies by technology, application and region
  • Information about food and drug administration guidelines and internal standards for DNA diagnostics, and coverage of novel therapeutic products and their approvals
  • Discussion on related issues, government regulations, and reimbursement through insurance, patient confidentiality and other legal ramifications
  • Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market trends, market size and forecast
  • Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
  • Company profiles of major players, including Abbott, Becton, Dickinson and Company, General Electric, Siemens Healthcare GmbH and Thermo Fisher Scientific Inc.

Table of Contents

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing the Study
  • Intended Audience
  • What's New in This Update?
  • Scope of Report
  • Methodology
  • Information Sources
  • Geographical Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Overview

  • Introduction to Genomic Diagnostics
  • Expression Profiling and Disease
  • Expression Profiling and Infectious Disease
  • DNA Sequencing for Genotyping and Diagnosis
  • Clinical Pharmacology
  • Mutation Detection and Genotyping for Specific Genes
  • Identification of New Disease Genes

Chapter 4 Impact of the COVID-19 Pandemic

  • Introduction
  • Impact of COVID-19 on Market
  • Changes in Consumption Trends for Health-Related Products

Chapter 5 Market Dynamics

  • Market Drivers
  • High Incidences of Infectious Diseases
  • Increasing Incidences of Chronic Disease
  • Increasing Research and Development Budget
  • Increasing Healthcare Expenditures
  • Restraints and Challenges
  • Stringent Regulatory Framework
  • High R&D and Marketing Costs
  • Opportunities
  • Point-of Care Tests that Minimize Dependency on Lab Testing
  • Discovery of New Biomarkers and Advances in Molecular Techniques

Chapter 6 Market Breakdown by Technology

  • Microarrays
  • Description
  • Microfluidic Devices
  • Market Size and Forecast
  • PCR
  • Market Size and Forecast
  • In Situ Hybridization
  • Labeling Techniques
  • In Situ Hybridization Applications
  • Fiber Fish
  • Her2 Fish Testing
  • Market Size and Forecast
  • Others
  • Trend Toward Single-Cell Measurements
  • Market Size and Forecast

Chapter 7 Molecular Diagnostics by Application

  • Infectious Diseases
  • Market Size and Forecast
  • Oncology
  • Leukemias
  • Chronic Myeloid Leukemia
  • Genetic Marker of Chronic Myeloid Leukemia
  • Market Size and Forecast
  • Pre- and Post-Natal Screening
  • Carrier Screening
  • Prenatal Diagnostic Testing
  • Amniocentesis
  • Chorionic Villus Sampling
  • Genetic Counseling
  • Preimplantation Diagnosis
  • Newborn Screening
  • Market Size and Forecast
  • Identity and Paternity
  • Paternity Testing
  • Technology
  • Accreditation
  • Legal Issues
  • Veterinary Identity Testing
  • Market Size and Forecast
  • Others
  • Market Size and Forecast

Chapter 8 Market Breakdown by Region

  • Global Molecular Diagnostic Market by Region
  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • Rest of Asia-Pacific
  • Rest of the World

Chapter 9 Regulations and Finance

  • Overview
  • Europe
  • U.S.
  • Japan
  • Insurance
  • Food and Drug Administration Guidelines
  • Internal Standards for DNA Diagnostics
  • Minimum Information about a Microarray
  • Experiment: MIAME 2.0
  • Microarray Quality Control Project
  • Clinical Laboratory Improvement Amendments
  • Personalized Medicines and Companion Diagnostics
  • FDA Guidelines for In Vitro Companion Diagnostics
  • Definition and Use of an IVD Companion Diagnostic Device
  • Review and Approval of IVD Companion Diagnostic Devices and Therapeutic Products
  • Novel Therapeutic Products
  • Approval of a Therapeutic Product without an Approved IVD Companion Diagnostic Device
  • General Policies
  • FDA Approved Companion Diagnostics
  • Nucleic Acid-Based Tests
  • Pharmacogenomics Research Network

Chapter 10 Patents

Chapter 11 Competitive Landscape

  • Overview

Chapter 12 Company Profiles

  • ABBOTT
  • AGILENT TECHNOLOGIES INC.
  • ALMAC GROUP
  • BECTON, DICKINSON AND CO.
  • BIOMERIEUX SA
  • BIO-RAD LABORATORIES INC.
  • CARDINAL HEALTH
  • DANAHER CORP.
  • ELITECH GROUP
  • GENERAL ELECTRIC
  • HOLOGIC INC.
  • ILLUMINA INC.
  • MYRIAD GENETICS
  • GRIFOLS (NOVARTIS MOLECULAR DIAGNOSTICS)
  • PHILIPS HEALTHCARE
  • QIAGEN N.V.
  • QUEST DIAGNOSTICS
  • ROCHE HOLDING AG (F. HOFFMANN-LA ROCHE LTD.)
  • SIEMENS HEALTHCARE
  • THERMO FISHER SCIENTIFIC INC.

List of Tables

  • Summary Table : Global Molecular Diagnostic Market, by Region, Through 2026
  • Table 1 : Global HIV Data, 2000-2020
  • Table 2 : Global Leading Causes of Disease, 2004 and 2030
  • Table 3 : National Institutes of Health Funding Estimates for Various Conditions and Diseases, 2014-2019
  • Table 4 : Global Molecular Diagnostic Market, by Technology, Through 2026
  • Table 5 : Global Molecular Diagnostic Market, by Application, Through 2026
  • Table 6 : Global Molecular Diagnostic Market, by Region, Through 2026
  • Table 7 : North American Molecular Diagnostic Market, by Technology, Through 2026
  • Table 8 : North American Molecular Diagnostic Market, by Application, Through 2026
  • Table 9 : North American Molecular Diagnostic Market, by Country, Through 2026
  • Table 10 : U.S. Estimated Number of New Cancer Cases, 2021
  • Table 11 : European Molecular Diagnostic Market, by Technology, Through 2026
  • Table 12 : European Molecular Diagnostic Market, by Application, Through 2026
  • Table 13 : European Molecular Diagnostic Market, by Country, Through 2026
  • Table 14 : Asia-Pacific Molecular Diagnostic Market, by Technology, Through 2026
  • Table 15 : Asia-Pacific Molecular Diagnostic Market, by Application, Through 2026
  • Table 16 : Asia-Pacific Molecular Diagnostic Market, by Country, Through 2026
  • Table 17 : Rest of the World Molecular Diagnostic Market, by Technology, Through 2026
  • Table 18 : Rest of the World Molecular Diagnostic Market, by Application, Through 2026
  • Table 19 : Class I and Class II Exempt Devices
  • Table 20 : Minimum Information About a Microarray Experiment: MIAME 2.0
  • Table 21 : Microarray Quality Control Project
  • Table 22 : U.S. Laboratories CLIA-Certified for Molecular Diagnostics and Number of Disease Tests
  • Table 23 : U.S. Genetic Testing Procedures, by Type, 2015
  • Table 24 : FDA-Approved In Vitro Companion Diagnostic Devices, June 1, 2017
  • Table 25 : Nucleic Acid-Based Tests Cleared or Approved by the Center for Devices and Radiological Health, June 1, 2017
  • Table 26 : Nucleic Acid-Based Tests Cleared or Approved by the Center for Devices and Radiological Health, June 1, 2017
  • Table 27 : Selected Molecular Diagnostics, 2020-2021
  • Table 28 : Global Molecular Diagnostic Market Shares, by Manufacturer, 2020
  • Table 29 : Abbott: Financials, 2016-2020
  • Table 30 : Abbott: Product Portfolio, by Business Segment
  • Table 31 : Abbott: Point of Care Diagnostic Products
  • Table 32 : Abbott: Recent Developments, October 2017-September 2021
  • Table 33 : Agilent Technologies Inc.: Product Portfolio
  • Table 34 : Almac Group: Product Portfolio
  • Table 35 : Becton, Dickinson and Company: Product Portfolio
  • Table 36 : bioMerieux S.A.: Product Portfolio
  • Table 37 : BioRad Laboratories: Product Portfolio
  • Table 38 : Cardinal Health Inc.: Product Portfolio
  • Table 39 : Danaher Corp.: Product Portfolio
  • Table 40 : ELITech Group: Product Portfolio
  • Table 41 : General Electric: Financial Performance, 2019 and 2020
  • Table 42 : General Electric Healthcare: Molecular Diagnostics Products
  • Table 43 : Hologic Inc.: Product Portfolio
  • Table 44 : Illumina Inc.: Product Portfolio
  • Table 45 : Myriad Genetics: Product Portfolio
  • Table 46 : Novartis Molecular Diagnostics: Product Portfolio
  • Table 47 : Philips Healthcare: Product Portfolio
  • Table 48 : Qiagen N.V.: Product Portfolio
  • Table 49 : Quest Diagnostics: Product Portfolio
  • Table 50 : F. Hoffmann-La Roche Ltd.: Financials, 2019
  • Table 51 : F. Hoffmann-La Roche Ltd.: Revenue, by Diagnostic Segment, 2016-2018
  • Table 52 : F. Hoffmann-La Roche Ltd.: Product Portfolio
  • Table 53 : F. Hoffmann-La Roche Ltd.: Recent Developments, June 2017-April 2020
  • Table 54 : Siemens Healthcare GmbH: Product Segments
  • Table 55 : Siemens Healthcare GmbH: Molecular Diagnostics Products
  • Table 56 : Siemens Healthcare GmbH: Financials, 2019
  • Table 57 : Siemens Healthcare GmbH: Key Developments
  • Table 58 : Thermo Fisher Scientific: Product Portfolio
  • Table 59 : Thermo Fisher Scientific: Key Developments, 2021

List of Figures

  • Summary Figure A : Global Molecular Diagnostic Market, by Region, 2019-2026
  • Summary Figure B : Global Molecular Diagnostic Market Shares, by Region, 2020
  • Figure 1 : Incidences of Diagnosed Infectious Disease, by Country, 2019
  • Figure 2 : Distribution of Malaria Cases, by Country, 2018
  • Figure 3 : Global Projections for Deaths from the Top Three Chronic Diseases, 2005-2030
  • Figure 4 : Increased Incidence of Cancer, 2012 and 2030
  • Figure 5 : Global Distribution of Deaths from Chronic Diseases, 2018
  • Figure 6 : Flow of Funding for Disease Research, 2014-2018
  • Figure 7 : Global Funding in Tuberculosis Research and Development, by Institutions, 2019
  • Figure 8 : Rising Trends in Healthcare Spending, by Institution, 2015-2040
  • Figure 9 : Global Molecular Diagnostic Market Shares, by Technology, 2020
  • Figure 10 : Global Molecular Diagnostic Market, by Technology, 2019-2026
  • Figure 11 : Global Microarray Market, 2019-2026
  • Figure 12 : Global PCR Market, 2019-2026
  • Figure 13 : Global ISH Market, 2019-2026
  • Figure 14 : Global Others Market, 2019-2026
  • Figure 15 : Global Molecular Diagnostic Market Shares, by Application, 2020
  • Figure 16 : Global Molecular Diagnostic Market, by Application, 2019-2026
  • Figure 17 : Global Infectious Disease Market, 2019-2026
  • Figure 18 : Global Oncology Market, 2019-2026
  • Figure 19 : Global Pre- and Post-Natal Screening Market, 2019-2026
  • Figure 20 : Global Identity and Paternity Market, 2019-2026
  • Figure 21 : Global Others Market, 2019-2026
  • Figure 22 : Global Molecular Diagnostic Market Shares, by Region, 2020
  • Figure 23 : North American Molecular Diagnostic Market Shares, by Technology, 2020
  • Figure 24 : North American Molecular Diagnostic Market Shares, by Application, 2020
  • Figure 25 : North American Molecular Diagnostic Market Shares, by Country, 2020
  • Figure 26 : U.S. Molecular Diagnostic Market, 2019-2026
  • Figure 27 : Canadian Molecular Diagnostic Market, 2019-2026
  • Figure 28 : European Molecular Diagnostic Market Shares, by Technology, 2020
  • Figure 29 : European Molecular Diagnostic Market Shares, by Application, 2020
  • Figure 30 : European Molecular Diagnostic Market Shares, by Country, 2020
  • Figure 31 : German Molecular Diagnostic Market, 2019-2026
  • Figure 32 : U.K. Molecular Diagnostic Market, 2019-2026
  • Figure 33 : French Molecular Diagnostic Market, 2019-2026
  • Figure 34 : Italy New Disease Cases, 2020
  • Figure 35 : Italian Molecular Diagnostic Market, 2019-2026
  • Figure 36 : Spain Share of New Cases, 2020
  • Figure 37 : Spanish Molecular Diagnostic Market, 2019-2026
  • Figure 38 : Rest of European Molecular Diagnostic Market, 2019-2026
  • Figure 39 : Asia-Pacific Molecular Diagnostic Market Shares, by Technology, 2020
  • Figure 40 : Asia-Pacific Molecular Diagnostic Market Shares, by Application, 2020
  • Figure 41 : Asia-Pacific Molecular Diagnostic Market Shares, by Country, 2020
  • Figure 42 : China New Cancer Cases, 2020
  • Figure 43 : China New Cancer Cases Share, 2020
  • Figure 44 : Chinese Molecular Diagnostic Market, 2019-2026
  • Figure 45 : Japanese Molecular Diagnostic Market, 2019-2026
  • Figure 46 : Indian Molecular Diagnostic Market, 2019-2026
  • Figure 47 : Rest of Asia-Pacific Molecular Diagnostic Market, 2019-2026
  • Figure 48 : Africa New Cancer Cases, 2020
  • Figure 49 : Rest of the World Molecular Diagnostic Market Shares, by Technology, 2020
  • Figure 50 : Rest of the World Molecular Diagnostic Market Shares, by Application, 2020
  • Figure 51 : U.S. Process for Marketing a Medical Device
  • Figure 52 : Growth in Clinical Laboratory Sites and Disease Testing, 2012-2015
  • Figure 53 : Global Molecular Diagnostic Market Shares, by Manufacturer, 2020
  • Figure 54 : Abbott: Revenue Share, by Region or Country,
  • Figure 55 : Abbott: Revenue Share, by Business Segment
  • Figure 56 : Becton, Dickinson and Company: Annual Revenue, 2018-2020
  • Figure 57 : Becton, Dickinson and Company: Revenue Share, by Region, 2020
  • Figure 58 : Becton, Dickinson and Company: Revenue Share, by Business Segment, 2020
  • Figure 59 : Danaher Corp.: Annual Revenue, 2018-2020
  • Figure 60 : Danaher Corp.: Revenue Share, by Geography, 2020
  • Figure 61 : Danaher Corp.: Revenue Share, by Segment, 2020
  • Figure 62 : General Electric: Revenue Share, by Business Segment, 2020
  • Figure 63 : General Electric Healthcare: Revenue Share, by Region, 2020
  • Figure 64 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Segment, 2019
  • Figure 65 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Region or Country, 2019
  • Figure 66 : Siemens Healthcare GmbH: Revenue Share, by Business Segment, 2019
  • Figure 67 : Siemens Healthcare GmbH: Revenue Share, by Region, 2019
  • Figure 68 : Thermo Fisher Scientific: Annual Revenue, 2019 and 2020
  • Figure 69 : Thermo Fisher Scientific: Revenue Share, by Region, 2020
  • Figure 70 : Thermo Fisher Scientific: Revenue Share, by Segment, 2020